Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Consensus Recommendation of “Hold” from Analysts
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have earned an average recommendation of “Hold” from the five research firms that are covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month target price among […]
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have earned an average recommendation of “Hold” from the five research firms that are covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month target price among […]
